

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.25767955 |
| 2 | central nervous system myelination (GO:0022010) | 8.25767955 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.76111271 |
| 4 | hepatocyte apoptotic process (GO:0097284) | 4.70336699 |
| 5 | ensheathment of neurons (GO:0007272) | 4.43117811 |
| 6 | axon ensheathment (GO:0008366) | 4.43117811 |
| 7 | myelination (GO:0042552) | 4.40292654 |
| 8 | L-amino acid import (GO:0043092) | 4.38426700 |
| 9 | response to interleukin-15 (GO:0070672) | 4.25014751 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 4.23864638 |
| 11 | positive T cell selection (GO:0043368) | 4.07299739 |
| 12 | myelin maintenance (GO:0043217) | 4.03588594 |
| 13 | positive regulation of granulocyte differentiation (GO:0030854) | 3.99920055 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.81922419 |
| 15 | positive thymic T cell selection (GO:0045059) | 3.80292826 |
| 16 | DNA deamination (GO:0045006) | 3.72293018 |
| 17 | response to methylmercury (GO:0051597) | 3.68445746 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68389125 |
| 19 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.66478293 |
| 20 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.66364677 |
| 21 | thrombin receptor signaling pathway (GO:0070493) | 3.62414175 |
| 22 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.53337671 |
| 23 | regulation of regulatory T cell differentiation (GO:0045589) | 3.52078524 |
| 24 | T cell migration (GO:0072678) | 3.46379129 |
| 25 | regulation of platelet aggregation (GO:0090330) | 3.45856765 |
| 26 | negative regulation of neurotransmitter transport (GO:0051589) | 3.45624630 |
| 27 | cytidine metabolic process (GO:0046087) | 3.45372204 |
| 28 | cytidine catabolic process (GO:0006216) | 3.45372204 |
| 29 | cytidine deamination (GO:0009972) | 3.45372204 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.43843489 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.43557311 |
| 32 | fatty acid elongation (GO:0030497) | 3.38579549 |
| 33 | nerve growth factor signaling pathway (GO:0038180) | 3.35363658 |
| 34 | adenosine receptor signaling pathway (GO:0001973) | 3.33639633 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.33196711 |
| 36 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.30439258 |
| 37 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.30439258 |
| 38 | regulation of B cell differentiation (GO:0045577) | 3.30418329 |
| 39 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.30328700 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30328494 |
| 41 | negative regulation of cell killing (GO:0031342) | 3.30328494 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29450944 |
| 43 | mast cell activation (GO:0045576) | 3.28702102 |
| 44 | dendritic cell migration (GO:0036336) | 3.26556221 |
| 45 | T cell selection (GO:0045058) | 3.24896807 |
| 46 | import into cell (GO:0098657) | 3.23620800 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23152504 |
| 48 | protein neddylation (GO:0045116) | 3.20868639 |
| 49 | neutrophil activation involved in immune response (GO:0002283) | 3.19648931 |
| 50 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.17187683 |
| 51 | synaptic vesicle maturation (GO:0016188) | 3.16340532 |
| 52 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.14894735 |
| 53 | activated T cell proliferation (GO:0050798) | 3.12928375 |
| 54 | interferon-gamma production (GO:0032609) | 3.10617754 |
| 55 | thymic T cell selection (GO:0045061) | 3.09772963 |
| 56 | histone mRNA catabolic process (GO:0071044) | 3.08856360 |
| 57 | negative T cell selection (GO:0043383) | 3.07501990 |
| 58 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.04999303 |
| 59 | negative regulation of T cell apoptotic process (GO:0070233) | 3.03889387 |
| 60 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.01539439 |
| 61 | amino acid import (GO:0043090) | 3.01330746 |
| 62 | negative thymic T cell selection (GO:0045060) | 3.01159589 |
| 63 | regulation of collateral sprouting (GO:0048670) | 3.00989385 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00862084 |
| 65 | cortical actin cytoskeleton organization (GO:0030866) | 3.00756207 |
| 66 | protein localization to endosome (GO:0036010) | 2.98893505 |
| 67 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.98794199 |
| 68 | B cell mediated immunity (GO:0019724) | 2.98668395 |
| 69 | response to lipoprotein particle (GO:0055094) | 2.98293567 |
| 70 | dendritic cell chemotaxis (GO:0002407) | 2.98166000 |
| 71 | negative regulation of B cell proliferation (GO:0030889) | 2.97814534 |
| 72 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94475760 |
| 73 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.93680682 |
| 74 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.92692524 |
| 75 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.92619379 |
| 76 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.92619379 |
| 77 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.91666605 |
| 78 | regulation of ARF GTPase activity (GO:0032312) | 2.90216845 |
| 79 | establishment of mitochondrion localization (GO:0051654) | 2.88663716 |
| 80 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.86438329 |
| 81 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.85408793 |
| 82 | protein K11-linked deubiquitination (GO:0035871) | 2.83924607 |
| 83 | T cell receptor signaling pathway (GO:0050852) | 2.82530142 |
| 84 | positive regulation of DNA recombination (GO:0045911) | 2.82344548 |
| 85 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.80473120 |
| 86 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.80103532 |
| 87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.79993667 |
| 88 | amyloid precursor protein metabolic process (GO:0042982) | 2.79528889 |
| 89 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79501489 |
| 90 | negative regulation of adaptive immune response (GO:0002820) | 2.79034279 |
| 91 | positive regulation of macrophage differentiation (GO:0045651) | 2.76566923 |
| 92 | positive regulation of mast cell activation (GO:0033005) | 2.76353634 |
| 93 | negative regulation of protein localization to cell surface (GO:2000009) | 2.76179802 |
| 94 | cortical cytoskeleton organization (GO:0030865) | 2.75450964 |
| 95 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.75335000 |
| 96 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.74939950 |
| 97 | Golgi to endosome transport (GO:0006895) | 2.73086025 |
| 98 | positive regulation of isotype switching (GO:0045830) | 2.72323108 |
| 99 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.71698731 |
| 100 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.71243482 |
| 101 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.71206805 |
| 102 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70729263 |
| 103 | adult walking behavior (GO:0007628) | 2.70656056 |
| 104 | positive regulation of Rap GTPase activity (GO:0032854) | 2.70560900 |
| 105 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.69708976 |
| 106 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.69685402 |
| 107 | glycine transport (GO:0015816) | 2.68435466 |
| 108 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.68364677 |
| 109 | cellular extravasation (GO:0045123) | 2.68143207 |
| 110 | glycosylceramide metabolic process (GO:0006677) | 2.67681684 |
| 111 | regulation of platelet activation (GO:0010543) | 2.67669017 |
| 112 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.67183116 |
| 113 | creatine metabolic process (GO:0006600) | 2.67178562 |
| 114 | B cell receptor signaling pathway (GO:0050853) | 2.66868119 |
| 115 | oligodendrocyte differentiation (GO:0048709) | 2.66846126 |
| 116 | immunoglobulin mediated immune response (GO:0016064) | 2.65920213 |
| 117 | mast cell degranulation (GO:0043303) | 2.65192068 |
| 118 | mast cell activation involved in immune response (GO:0002279) | 2.65192068 |
| 119 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.63466797 |
| 120 | positive regulation of B cell mediated immunity (GO:0002714) | 2.63466797 |
| 121 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.63408144 |
| 122 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.62851106 |
| 123 | neutrophil activation (GO:0042119) | 2.62462480 |
| 124 | neurotransmitter uptake (GO:0001504) | 2.60794458 |
| 125 | negative regulation of B cell activation (GO:0050869) | 2.57870605 |
| 126 | membrane raft organization (GO:0031579) | 2.55760079 |
| 127 | myeloid cell activation involved in immune response (GO:0002275) | 2.54996774 |
| 128 | actin nucleation (GO:0045010) | 2.54892546 |
| 129 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.52022397 |
| 130 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.51647753 |
| 131 | granulocyte activation (GO:0036230) | 2.50687177 |
| 132 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.50460514 |
| 133 | regulation of Rap GTPase activity (GO:0032317) | 2.50319424 |
| 134 | microglial cell activation (GO:0001774) | 2.50305582 |
| 135 | positive regulation of gliogenesis (GO:0014015) | 2.49696611 |
| 136 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.49652038 |
| 137 | positive regulation of T cell cytokine production (GO:0002726) | 2.43564657 |
| 138 | positive regulation of interleukin-2 production (GO:0032743) | 2.43411346 |
| 139 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.42981183 |
| 140 | positive regulation by symbiont of host defense response (GO:0052509) | 2.42543718 |
| 141 | modulation by symbiont of host defense response (GO:0052031) | 2.42543718 |
| 142 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.42543718 |
| 143 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.42543718 |
| 144 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.42543718 |
| 145 | modulation by symbiont of host immune response (GO:0052553) | 2.42543718 |
| 146 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.41690046 |
| 147 | response to nerve growth factor (GO:1990089) | 2.41690046 |
| 148 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.41215464 |
| 149 | regulation of beta-amyloid formation (GO:1902003) | 2.40057271 |
| 150 | membrane tubulation (GO:0097320) | 2.39510108 |
| 151 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.39302696 |
| 152 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.38848496 |
| 153 | positive regulation of glial cell differentiation (GO:0045687) | 2.38834071 |
| 154 | leukocyte degranulation (GO:0043299) | 2.38820784 |
| 155 | axon development (GO:0061564) | 2.38447984 |
| 156 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.38095983 |
| 157 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36339548 |
| 158 | tolerance induction (GO:0002507) | 2.36230094 |
| 159 | neuronal action potential propagation (GO:0019227) | 2.35969942 |
| 160 | negative regulation of inclusion body assembly (GO:0090084) | 2.34693352 |
| 161 | positive regulation of macrophage cytokine production (GO:0060907) | 2.34159671 |
| 162 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.31140664 |
| 163 | positive regulation of chemokine secretion (GO:0090197) | 2.28947023 |
| 164 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.28297781 |
| 165 | leukocyte aggregation (GO:0070486) | 2.27735725 |
| 166 | regulation of T cell tolerance induction (GO:0002664) | 2.26972587 |
| 167 | astrocyte development (GO:0014002) | 2.26327094 |
| 168 | macrophage activation involved in immune response (GO:0002281) | 2.25598503 |
| 169 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.25044515 |
| 170 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.25044515 |
| 171 | Rac protein signal transduction (GO:0016601) | 2.24923081 |
| 172 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.23666314 |
| 173 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.20765357 |
| 174 | positive regulation of pseudopodium assembly (GO:0031274) | 2.20341620 |
| 175 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.20239101 |
| 176 | protein palmitoylation (GO:0018345) | 2.19663196 |
| 177 | negative regulation of axonogenesis (GO:0050771) | 2.19490580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.48108011 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22123667 |
| 3 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.13586137 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.94680261 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.77056253 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.70189876 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.57220063 |
| 8 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.51174645 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49882497 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.38518263 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09955027 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.07511576 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.06527237 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01803997 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.01511881 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.93245155 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92768216 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92657691 |
| 19 | GATA3_26560356_Chip-Seq_TH2_Human | 1.91230556 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.88555235 |
| 21 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.86816872 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.83000374 |
| 23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.78479997 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77043737 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74708198 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68677933 |
| 27 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65928548 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65474017 |
| 29 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.64821882 |
| 30 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.64117594 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.63998324 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.59231530 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56781930 |
| 34 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.53669018 |
| 35 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52668906 |
| 36 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.51796086 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51790434 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49535578 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49523404 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49028749 |
| 41 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.47518614 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46456797 |
| 43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.44049722 |
| 44 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43127582 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42881597 |
| 46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.40908871 |
| 47 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40463690 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39366935 |
| 49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38242813 |
| 50 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38242813 |
| 51 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.36233757 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36212506 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34537731 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33958593 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.33897609 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33160167 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28291798 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26662880 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26110514 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25973931 |
| 61 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25730924 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25329417 |
| 63 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.24269898 |
| 64 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23783656 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23257637 |
| 66 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.23001588 |
| 67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.22911194 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22562462 |
| 69 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22150978 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21496799 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21480409 |
| 72 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.20579449 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20546333 |
| 74 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20133404 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19070672 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18811148 |
| 77 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.16408722 |
| 78 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.15855437 |
| 79 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15449180 |
| 80 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.14741518 |
| 81 | GATA3_26560356_Chip-Seq_TH1_Human | 1.12476556 |
| 82 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12235430 |
| 83 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11771860 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11611977 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10283229 |
| 86 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10281695 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09803399 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09385713 |
| 89 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09235188 |
| 90 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08486971 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08067897 |
| 92 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07662593 |
| 93 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07252070 |
| 94 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06780993 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05642825 |
| 96 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04550876 |
| 97 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.03996630 |
| 98 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03571837 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02948893 |
| 100 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02780389 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01977490 |
| 102 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01942305 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01840436 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01607519 |
| 105 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01342440 |
| 106 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01311413 |
| 107 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00722372 |
| 108 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.00533239 |
| 109 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00043467 |
| 110 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99737734 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98652233 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97708213 |
| 113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97520049 |
| 114 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97508357 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96366378 |
| 116 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96031267 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95876501 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95841388 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95722517 |
| 120 | * MAF_26560356_Chip-Seq_TH1_Human | 0.95537371 |
| 121 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95367705 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93797019 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93649948 |
| 124 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93528614 |
| 125 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93490396 |
| 126 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93109221 |
| 127 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93065701 |
| 128 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92815751 |
| 129 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91840283 |
| 130 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90806096 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90598439 |
| 132 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90291781 |
| 133 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90146369 |
| 134 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90028338 |
| 135 | MYB_26560356_Chip-Seq_TH1_Human | 0.89255579 |
| 136 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.88779821 |
| 137 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.88541109 |
| 138 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88397146 |
| 139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88355244 |
| 140 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88340470 |
| 141 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.88288840 |
| 142 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87627843 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87610741 |
| 144 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.87446862 |
| 145 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86963174 |
| 146 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86600663 |
| 147 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.86512566 |
| 148 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.86052335 |
| 149 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85798153 |
| 150 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.85705922 |
| 151 | STAT3_23295773_ChIP-Seq_U87_Human | 0.85572852 |
| 152 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.85517813 |
| 153 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85334752 |
| 154 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.85152683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.57184478 |
| 2 | MP0003690_abnormal_glial_cell | 3.24542318 |
| 3 | MP0003880_abnormal_central_pattern | 3.03170412 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.84377379 |
| 5 | MP0000372_irregular_coat_pigmentation | 2.80650279 |
| 6 | MP0006082_CNS_inflammation | 2.79258268 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.74333301 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 2.71313030 |
| 9 | MP0003303_peritoneal_inflammation | 2.41626211 |
| 10 | MP0005671_abnormal_response_to | 2.36872062 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.32106023 |
| 12 | MP0004381_abnormal_hair_follicle | 2.31255963 |
| 13 | MP0004510_myositis | 2.29096859 |
| 14 | MP0004270_analgesia | 2.28639513 |
| 15 | MP0001790_abnormal_immune_system | 2.24853353 |
| 16 | MP0005387_immune_system_phenotype | 2.24853353 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.18450303 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.17299920 |
| 19 | MP0000685_abnormal_immune_system | 2.11012561 |
| 20 | MP0003329_amyloid_beta_deposits | 2.07351732 |
| 21 | MP0002064_seizures | 2.06746422 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.00585132 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.98846697 |
| 24 | MP0002419_abnormal_innate_immunity | 1.92650157 |
| 25 | MP0001800_abnormal_humoral_immune | 1.92067716 |
| 26 | MP0001486_abnormal_startle_reflex | 1.90728871 |
| 27 | MP0002272_abnormal_nervous_system | 1.87598746 |
| 28 | MP0002723_abnormal_immune_serum | 1.85193054 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.81378378 |
| 30 | MP0003787_abnormal_imprinting | 1.80735016 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 1.80287023 |
| 32 | MP0003634_abnormal_glial_cell | 1.77944918 |
| 33 | MP0000604_amyloidosis | 1.77820247 |
| 34 | MP0005409_darkened_coat_color | 1.72895624 |
| 35 | MP0005310_abnormal_salivary_gland | 1.72426930 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.70144157 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.69956381 |
| 38 | MP0004742_abnormal_vestibular_system | 1.68611803 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.66597984 |
| 40 | MP0001819_abnormal_immune_cell | 1.66053918 |
| 41 | MP0003633_abnormal_nervous_system | 1.63227781 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.62938977 |
| 43 | MP0003866_abnormal_defecation | 1.61505216 |
| 44 | MP0006054_spinal_hemorrhage | 1.60187010 |
| 45 | MP0001851_eye_inflammation | 1.59763583 |
| 46 | MP0005025_abnormal_response_to | 1.57616144 |
| 47 | MP0004885_abnormal_endolymph | 1.56987825 |
| 48 | MP0009745_abnormal_behavioral_response | 1.56450567 |
| 49 | MP0003075_altered_response_to | 1.55852180 |
| 50 | MP0001348_abnormal_lacrimal_gland | 1.53436757 |
| 51 | MP0008569_lethality_at_weaning | 1.48938128 |
| 52 | MP0004142_abnormal_muscle_tone | 1.44419171 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.44335870 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.43604346 |
| 55 | MP0003631_nervous_system_phenotype | 1.36918794 |
| 56 | MP0001905_abnormal_dopamine_level | 1.33969630 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.33669399 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.33602086 |
| 59 | MP0009046_muscle_twitch | 1.33552756 |
| 60 | MP0000716_abnormal_immune_system | 1.28717386 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.27821227 |
| 62 | MP0009785_altered_susceptibility_to | 1.27347554 |
| 63 | MP0002063_abnormal_learning/memory/cond | 1.25531453 |
| 64 | MP0002095_abnormal_skin_pigmentation | 1.25506922 |
| 65 | MP0002398_abnormal_bone_marrow | 1.23886080 |
| 66 | MP0001970_abnormal_pain_threshold | 1.23526564 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.23501620 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.20431742 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.20431742 |
| 70 | MP0002405_respiratory_system_inflammati | 1.20322969 |
| 71 | MP0002229_neurodegeneration | 1.19154790 |
| 72 | MP0003436_decreased_susceptibility_to | 1.16763959 |
| 73 | MP0003632_abnormal_nervous_system | 1.14333834 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 1.13460849 |
| 75 | MP0005408_hypopigmentation | 1.11948650 |
| 76 | MP0000569_abnormal_digit_pigmentation | 1.10213614 |
| 77 | MP0008057_abnormal_DNA_replication | 1.09234356 |
| 78 | MP0005171_absent_coat_pigmentation | 1.07793916 |
| 79 | MP0008260_abnormal_autophagy | 1.07457776 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.07368721 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 1.07288964 |
| 82 | MP0002166_altered_tumor_susceptibility | 1.04498878 |
| 83 | MP0002933_joint_inflammation | 1.03755488 |
| 84 | MP0002734_abnormal_mechanical_nocicepti | 1.03139127 |
| 85 | MP0004484_altered_response_of | 1.01026236 |
| 86 | MP0008872_abnormal_physiological_respon | 1.00460535 |
| 87 | MP0002067_abnormal_sensory_capabilities | 0.98880084 |
| 88 | MP0001968_abnormal_touch/_nociception | 0.98651598 |
| 89 | MP0004947_skin_inflammation | 0.97752743 |
| 90 | MP0008874_decreased_physiological_sensi | 0.95381228 |
| 91 | MP0009764_decreased_sensitivity_to | 0.95120334 |
| 92 | MP0001501_abnormal_sleep_pattern | 0.94046111 |
| 93 | MP0000689_abnormal_spleen_morphology | 0.92499521 |
| 94 | MP0003828_pulmonary_edema | 0.92259779 |
| 95 | MP0003724_increased_susceptibility_to | 0.92230963 |
| 96 | MP0002006_tumorigenesis | 0.92227164 |
| 97 | MP0008004_abnormal_stomach_pH | 0.91617918 |
| 98 | MP0005174_abnormal_tail_pigmentation | 0.91310161 |
| 99 | MP0009763_increased_sensitivity_to | 0.91211357 |
| 100 | MP0009840_abnormal_foam_cell | 0.90976854 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.90315619 |
| 102 | MP0002429_abnormal_blood_cell | 0.89832295 |
| 103 | MP0002733_abnormal_thermal_nociception | 0.89224470 |
| 104 | MP0003045_fibrosis | 0.88978324 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.88966944 |
| 106 | MP0000778_abnormal_nervous_system | 0.88686079 |
| 107 | MP0001485_abnormal_pinna_reflex | 0.88389700 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.87917999 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.87340453 |
| 110 | MP0000955_abnormal_spinal_cord | 0.86466215 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.86361610 |
| 112 | MP0000371_diluted_coat_color | 0.85860230 |
| 113 | MP0004147_increased_porphyrin_level | 0.85025034 |
| 114 | MP0002066_abnormal_motor_capabilities/c | 0.83313806 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.82801820 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.82534157 |
| 117 | MP0001853_heart_inflammation | 0.82492209 |
| 118 | MP0001529_abnormal_vocalization | 0.82487772 |
| 119 | MP0004883_abnormal_blood_vessel | 0.81324869 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.80196694 |
| 121 | MP0002102_abnormal_ear_morphology | 0.80088344 |
| 122 | MP0002722_abnormal_immune_system | 0.79369063 |
| 123 | MP0005083_abnormal_biliary_tract | 0.79100374 |
| 124 | MP0001440_abnormal_grooming_behavior | 0.78701074 |
| 125 | MP0001845_abnormal_inflammatory_respons | 0.78375292 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.77729379 |
| 127 | MP0006036_abnormal_mitochondrial_physio | 0.77165897 |
| 128 | MP0002736_abnormal_nociception_after | 0.77006887 |
| 129 | MP0005166_decreased_susceptibility_to | 0.76876722 |
| 130 | MP0008873_increased_physiological_sensi | 0.76364178 |
| 131 | MP0003448_altered_tumor_morphology | 0.73527784 |
| 132 | MP0002132_abnormal_respiratory_system | 0.71761935 |
| 133 | MP0005084_abnormal_gallbladder_morpholo | 0.71257197 |
| 134 | MP0008469_abnormal_protein_level | 0.69574580 |
| 135 | MP0000343_altered_response_to | 0.67950964 |
| 136 | MP0000858_altered_metastatic_potential | 0.67514653 |
| 137 | MP0004808_abnormal_hematopoietic_stem | 0.66433592 |
| 138 | MP0003806_abnormal_nucleotide_metabolis | 0.65617284 |
| 139 | MP0003786_premature_aging | 0.61817627 |
| 140 | MP0003195_calcinosis | 0.61512467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Peripheral hypomyelination (HP:0007182) | 5.45744613 |
| 2 | Neurofibrillary tangles (HP:0002185) | 5.33635990 |
| 3 | Prolonged bleeding time (HP:0003010) | 5.10925324 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.63919231 |
| 5 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.63919231 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 4.61862590 |
| 7 | Petechiae (HP:0000967) | 4.18347861 |
| 8 | Epistaxis (HP:0000421) | 3.94558185 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.92864898 |
| 10 | Onion bulb formation (HP:0003383) | 3.91175776 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 3.84040600 |
| 12 | Abnormality of T cells (HP:0002843) | 3.82344103 |
| 13 | Gingival bleeding (HP:0000225) | 3.79780411 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.68048581 |
| 15 | Axonal loss (HP:0003447) | 3.64344603 |
| 16 | Abnormality of the corticospinal tract (HP:0002492) | 3.62613426 |
| 17 | IgG deficiency (HP:0004315) | 3.56361092 |
| 18 | Abnormal platelet volume (HP:0011876) | 3.51631935 |
| 19 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.47714508 |
| 20 | Increased mean platelet volume (HP:0011877) | 3.46435453 |
| 21 | Slow saccadic eye movements (HP:0000514) | 3.43843111 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.34229289 |
| 23 | Encephalitis (HP:0002383) | 3.22472212 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.21839858 |
| 25 | Menorrhagia (HP:0000132) | 3.20934973 |
| 26 | Insidious onset (HP:0003587) | 3.17688318 |
| 27 | Termporal pattern (HP:0011008) | 3.17688318 |
| 28 | Abnormality of eosinophils (HP:0001879) | 3.14395090 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.11037290 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.11037290 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.11037290 |
| 32 | Increased IgM level (HP:0003496) | 3.10756654 |
| 33 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.07523675 |
| 34 | Ankle clonus (HP:0011448) | 3.07503482 |
| 35 | Spontaneous hematomas (HP:0007420) | 3.06698058 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 3.05957532 |
| 37 | Severe combined immunodeficiency (HP:0004430) | 3.04359489 |
| 38 | Spastic gait (HP:0002064) | 3.01392183 |
| 39 | Myokymia (HP:0002411) | 3.00945643 |
| 40 | Dysmetria (HP:0001310) | 2.97052802 |
| 41 | Ocular albinism (HP:0001107) | 2.94532828 |
| 42 | Poikilocytosis (HP:0004447) | 2.93513587 |
| 43 | Abnormality of the prostate (HP:0008775) | 2.93012049 |
| 44 | Stomatitis (HP:0010280) | 2.91252176 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89166789 |
| 46 | Purpura (HP:0000979) | 2.89141613 |
| 47 | Eczematoid dermatitis (HP:0000976) | 2.84710300 |
| 48 | Abnormality of T cell number (HP:0011839) | 2.83639463 |
| 49 | Recurrent viral infections (HP:0004429) | 2.83499013 |
| 50 | Visual hallucinations (HP:0002367) | 2.81913206 |
| 51 | Parakeratosis (HP:0001036) | 2.80497681 |
| 52 | T lymphocytopenia (HP:0005403) | 2.80051741 |
| 53 | Abnormal auditory evoked potentials (HP:0006958) | 2.79137677 |
| 54 | Chest pain (HP:0100749) | 2.78534311 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.78354225 |
| 56 | Gastrointestinal infarctions (HP:0005244) | 2.76818293 |
| 57 | Action tremor (HP:0002345) | 2.72917303 |
| 58 | Arterial thrombosis (HP:0004420) | 2.72468188 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.71119688 |
| 60 | Intention tremor (HP:0002080) | 2.68705833 |
| 61 | Granulocytopenia (HP:0001913) | 2.68333696 |
| 62 | Chronic otitis media (HP:0000389) | 2.67589493 |
| 63 | Recurrent skin infections (HP:0001581) | 2.66860605 |
| 64 | Orchitis (HP:0100796) | 2.66714248 |
| 65 | Neuronal loss in central nervous system (HP:0002529) | 2.66398161 |
| 66 | Iris hypopigmentation (HP:0007730) | 2.58923946 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.57990488 |
| 68 | Abnormality of macrophages (HP:0004311) | 2.57172067 |
| 69 | Loss of speech (HP:0002371) | 2.56871251 |
| 70 | Hypochromic microcytic anemia (HP:0004840) | 2.56833795 |
| 71 | Abnormal platelet function (HP:0011869) | 2.52853722 |
| 72 | Impaired platelet aggregation (HP:0003540) | 2.52853722 |
| 73 | Dyschromatopsia (HP:0007641) | 2.51439202 |
| 74 | Joint swelling (HP:0001386) | 2.45123539 |
| 75 | Cellulitis (HP:0100658) | 2.44512281 |
| 76 | Scanning speech (HP:0002168) | 2.42785432 |
| 77 | Combined immunodeficiency (HP:0005387) | 2.41204381 |
| 78 | Mutism (HP:0002300) | 2.37649500 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.35330321 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.35142066 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.34661546 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.33114809 |
| 83 | Recurrent bronchitis (HP:0002837) | 2.32724598 |
| 84 | Hypoproteinemia (HP:0003075) | 2.31938404 |
| 85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30085544 |
| 86 | Abnormality of binocular vision (HP:0011514) | 2.29307795 |
| 87 | Diplopia (HP:0000651) | 2.29307795 |
| 88 | Focal motor seizures (HP:0011153) | 2.27870396 |
| 89 | Sensory axonal neuropathy (HP:0003390) | 2.27548204 |
| 90 | Clumsiness (HP:0002312) | 2.27466331 |
| 91 | Pustule (HP:0200039) | 2.27435468 |
| 92 | Cerebral hypomyelination (HP:0006808) | 2.26776031 |
| 93 | Pulmonary embolism (HP:0002204) | 2.26053526 |
| 94 | Peripheral demyelination (HP:0011096) | 2.25087935 |
| 95 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.21195931 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.20954275 |
| 97 | Disinhibition (HP:0000734) | 2.20689426 |
| 98 | IgM deficiency (HP:0002850) | 2.20496179 |
| 99 | Urinary urgency (HP:0000012) | 2.19629199 |
| 100 | Agammaglobulinemia (HP:0004432) | 2.19100326 |
| 101 | Cerebral hemorrhage (HP:0001342) | 2.18968858 |
| 102 | Albinism (HP:0001022) | 2.18673831 |
| 103 | Apathy (HP:0000741) | 2.17636521 |
| 104 | Autoimmune thrombocytopenia (HP:0001973) | 2.17262146 |
| 105 | Stomach cancer (HP:0012126) | 2.16305233 |
| 106 | Dysostosis multiplex (HP:0000943) | 2.14575653 |
| 107 | Amaurosis fugax (HP:0100576) | 2.13053969 |
| 108 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11943335 |
| 109 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11943335 |
| 110 | Lower limb muscle weakness (HP:0007340) | 2.11014110 |
| 111 | Microcytic anemia (HP:0001935) | 2.10693236 |
| 112 | Hemoptysis (HP:0002105) | 2.09548339 |
| 113 | Chronic diarrhea (HP:0002028) | 2.09259017 |
| 114 | Obstructive lung disease (HP:0006536) | 2.09096742 |
| 115 | Chronic obstructive pulmonary disease (HP:0006510) | 2.09096742 |
| 116 | Abnormality of the periventricular white matter (HP:0002518) | 2.07652679 |
| 117 | Lymphopenia (HP:0001888) | 2.06993153 |
| 118 | Decreased motor nerve conduction velocity (HP:0003431) | 2.06803044 |
| 119 | Papilledema (HP:0001085) | 2.05009211 |
| 120 | Hemiplegia (HP:0002301) | 2.02970295 |
| 121 | Inflammation of the large intestine (HP:0002037) | 2.02635920 |
| 122 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.02534304 |
| 123 | Hypochromic anemia (HP:0001931) | 2.02481210 |
| 124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01315309 |
| 125 | Colitis (HP:0002583) | 2.00981872 |
| 126 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00969961 |
| 127 | Vasculitis (HP:0002633) | 1.98911857 |
| 128 | Conjunctival telangiectasia (HP:0000524) | 1.98158400 |
| 129 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97549856 |
| 130 | Anorexia (HP:0002039) | 1.97053983 |
| 131 | Hyperlipoproteinemia (HP:0010980) | 1.96810851 |
| 132 | Delusions (HP:0000746) | 1.96717167 |
| 133 | Vertigo (HP:0002321) | 1.96135994 |
| 134 | Meningitis (HP:0001287) | 1.96093066 |
| 135 | Foot dorsiflexor weakness (HP:0009027) | 1.95640671 |
| 136 | Generalized hypopigmentation (HP:0007513) | 1.95451425 |
| 137 | Focal seizures (HP:0007359) | 1.95416863 |
| 138 | Urinary incontinence (HP:0000020) | 1.94929647 |
| 139 | Acanthocytosis (HP:0001927) | 1.94750153 |
| 140 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.93520512 |
| 141 | IgA deficiency (HP:0002720) | 1.92974698 |
| 142 | Lymphoma (HP:0002665) | 1.92515744 |
| 143 | Spastic tetraparesis (HP:0001285) | 1.92389261 |
| 144 | Postural instability (HP:0002172) | 1.91663474 |
| 145 | Amyloidosis (HP:0011034) | 1.91371684 |
| 146 | Mediastinal lymphadenopathy (HP:0100721) | 1.90947291 |
| 147 | Diminished motivation (HP:0000745) | 1.90287635 |
| 148 | B lymphocytopenia (HP:0010976) | 1.89224501 |
| 149 | Myositis (HP:0100614) | 1.89042678 |
| 150 | Abnormality of saccadic eye movements (HP:0000570) | 1.87613343 |
| 151 | Thyroiditis (HP:0100646) | 1.86374005 |
| 152 | Leukocytosis (HP:0001974) | 1.84636187 |
| 153 | Epileptic encephalopathy (HP:0200134) | 1.84394972 |
| 154 | Retrobulbar optic neuritis (HP:0100654) | 1.82550365 |
| 155 | Optic neuritis (HP:0100653) | 1.82550365 |
| 156 | Metabolic alkalosis (HP:0200114) | 1.82044077 |
| 157 | Premature skin wrinkling (HP:0100678) | 1.81876295 |
| 158 | Progressive neurologic deterioration (HP:0002344) | 1.81498501 |
| 159 | Rapidly progressive (HP:0003678) | 1.80668767 |
| 160 | Partial duplication of thumb phalanx (HP:0009944) | 1.80241091 |
| 161 | Systemic lupus erythematosus (HP:0002725) | 1.79630607 |
| 162 | Eosinophilia (HP:0001880) | 1.78440382 |
| 163 | Gastrointestinal inflammation (HP:0004386) | 1.78170972 |
| 164 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77245778 |
| 165 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.77111998 |
| 166 | Hammertoe (HP:0001765) | 1.75034946 |
| 167 | Arterial tortuosity (HP:0005116) | 1.74202833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.66402506 |
| 2 | TAOK3 | 3.52756943 |
| 3 | EPHB1 | 3.27007989 |
| 4 | MAP4K1 | 2.74846876 |
| 5 | MAPKAPK5 | 2.70048142 |
| 6 | PLK2 | 2.58710440 |
| 7 | EIF2AK1 | 2.56346098 |
| 8 | OXSR1 | 2.53837814 |
| 9 | RIPK4 | 2.51166795 |
| 10 | SIK3 | 2.50058391 |
| 11 | BLK | 2.42667400 |
| 12 | PKN1 | 2.40723406 |
| 13 | CLK1 | 2.35239927 |
| 14 | FRK | 2.31141872 |
| 15 | TEC | 2.29187389 |
| 16 | MAP3K13 | 2.08789143 |
| 17 | TRIM28 | 1.96699299 |
| 18 | WNK1 | 1.91161783 |
| 19 | NUAK1 | 1.77105579 |
| 20 | ACVR1B | 1.74537459 |
| 21 | FES | 1.61051275 |
| 22 | CSF1R | 1.58665055 |
| 23 | EIF2AK3 | 1.57057561 |
| 24 | UHMK1 | 1.53770334 |
| 25 | FGR | 1.48622060 |
| 26 | TXK | 1.48472952 |
| 27 | IRAK4 | 1.45537441 |
| 28 | ITK | 1.44086559 |
| 29 | CDK19 | 1.42548911 |
| 30 | FGFR2 | 1.37069712 |
| 31 | MARK3 | 1.36803034 |
| 32 | MAP3K14 | 1.36162112 |
| 33 | TESK2 | 1.36086512 |
| 34 | TGFBR2 | 1.33481510 |
| 35 | CAMKK2 | 1.30850659 |
| 36 | KSR2 | 1.30062711 |
| 37 | SGK494 | 1.29588319 |
| 38 | SGK223 | 1.29588319 |
| 39 | PIK3CG | 1.28427727 |
| 40 | NTRK1 | 1.27513584 |
| 41 | PRKCQ | 1.21535338 |
| 42 | GRK7 | 1.20809431 |
| 43 | CSK | 1.19006981 |
| 44 | SYK | 1.18920069 |
| 45 | HCK | 1.18445432 |
| 46 | PLK3 | 1.16932591 |
| 47 | BMPR2 | 1.16158903 |
| 48 | STK10 | 1.13608869 |
| 49 | TYK2 | 1.13555957 |
| 50 | KIT | 1.05096169 |
| 51 | TBK1 | 1.04586321 |
| 52 | PAK6 | 1.02902379 |
| 53 | JAK1 | 1.01391920 |
| 54 | ROCK2 | 1.00958924 |
| 55 | ERBB3 | 1.00313483 |
| 56 | LCK | 0.99943873 |
| 57 | NEK6 | 0.96760933 |
| 58 | CAMK2B | 0.96683258 |
| 59 | GRK5 | 0.94791069 |
| 60 | CSNK1A1L | 0.93698086 |
| 61 | IKBKB | 0.93374897 |
| 62 | PAK3 | 0.93170835 |
| 63 | MAP3K9 | 0.92013935 |
| 64 | DMPK | 0.91341342 |
| 65 | SIK2 | 0.89896953 |
| 66 | LIMK1 | 0.87119645 |
| 67 | CDK5 | 0.86117983 |
| 68 | CAMK1G | 0.84904312 |
| 69 | PDK1 | 0.82055663 |
| 70 | PRKCH | 0.81959950 |
| 71 | PIM1 | 0.81755705 |
| 72 | MARK2 | 0.81550503 |
| 73 | FYN | 0.81230673 |
| 74 | GRK6 | 0.81000540 |
| 75 | PTK2B | 0.80259848 |
| 76 | MST4 | 0.79917051 |
| 77 | WNK4 | 0.79349718 |
| 78 | PDPK1 | 0.77980646 |
| 79 | ZAP70 | 0.77919702 |
| 80 | TNIK | 0.77887292 |
| 81 | TYRO3 | 0.75517672 |
| 82 | STK4 | 0.73664137 |
| 83 | IKBKE | 0.72451780 |
| 84 | STK11 | 0.71056177 |
| 85 | HIPK2 | 0.70574503 |
| 86 | EPHA4 | 0.70211020 |
| 87 | MINK1 | 0.69305016 |
| 88 | CSNK1G3 | 0.69247059 |
| 89 | MAPK7 | 0.68584498 |
| 90 | BCR | 0.68491492 |
| 91 | PDGFRB | 0.68076767 |
| 92 | RET | 0.65484574 |
| 93 | MAPK15 | 0.64381376 |
| 94 | DAPK1 | 0.63917535 |
| 95 | MAPK12 | 0.63285985 |
| 96 | BTK | 0.63186013 |
| 97 | ADRBK1 | 0.62745218 |
| 98 | MAP3K12 | 0.62094664 |
| 99 | PNCK | 0.61915589 |
| 100 | MAPKAPK3 | 0.61190244 |
| 101 | BMPR1B | 0.60104387 |
| 102 | CAMK2D | 0.58911605 |
| 103 | MAP3K2 | 0.58839436 |
| 104 | LYN | 0.58778758 |
| 105 | JAK2 | 0.58548058 |
| 106 | MAP2K3 | 0.58169108 |
| 107 | MAP4K2 | 0.57906195 |
| 108 | ADRBK2 | 0.57117415 |
| 109 | RAF1 | 0.56397122 |
| 110 | * PRKD1 | 0.55611543 |
| 111 | CSNK1G2 | 0.55280538 |
| 112 | MAPK13 | 0.54310130 |
| 113 | SGK2 | 0.54094489 |
| 114 | MAP3K1 | 0.52451754 |
| 115 | MOS | 0.51058050 |
| 116 | ALK | 0.50843699 |
| 117 | CSNK1G1 | 0.50526750 |
| 118 | MAP3K3 | 0.50492108 |
| 119 | MAPKAPK2 | 0.49631985 |
| 120 | CAMK2G | 0.49596106 |
| 121 | MATK | 0.48891095 |
| 122 | CAMKK1 | 0.48847753 |
| 123 | BUB1 | 0.48500350 |
| 124 | TRPM7 | 0.48000424 |
| 125 | BMX | 0.47857086 |
| 126 | TNK2 | 0.47458150 |
| 127 | CAMK2A | 0.45823712 |
| 128 | JAK3 | 0.45699479 |
| 129 | NLK | 0.45158122 |
| 130 | EIF2AK2 | 0.44837562 |
| 131 | IGF1R | 0.44216362 |
| 132 | NTRK2 | 0.43511537 |
| 133 | DYRK1A | 0.43112935 |
| 134 | ERBB2 | 0.43102015 |
| 135 | KSR1 | 0.42332507 |
| 136 | GSK3A | 0.42055732 |
| 137 | PRPF4B | 0.41763086 |
| 138 | DAPK2 | 0.41373275 |
| 139 | MET | 0.40900598 |
| 140 | EGFR | 0.38864467 |
| 141 | MYLK | 0.37112117 |
| 142 | PLK4 | 0.36183584 |
| 143 | KDR | 0.35549767 |
| 144 | YES1 | 0.33418759 |
| 145 | FGFR3 | 0.32961870 |
| 146 | ABL1 | 0.32697582 |
| 147 | BRSK2 | 0.31931615 |
| 148 | IRAK1 | 0.31010694 |
| 149 | MAP3K5 | 0.30856220 |
| 150 | SGK3 | 0.28452378 |
| 151 | FER | 0.27640859 |
| 152 | PAK1 | 0.26436918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.26790522 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.99859325 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.90126984 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.81758400 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.81158434 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77330286 |
| 7 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.67346507 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.66136093 |
| 9 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.60684138 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.58339488 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.57418583 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56817050 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49564895 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.39269259 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38896064 |
| 16 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.38094460 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.37097337 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.36790649 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.34905304 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33408182 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32505763 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.31409535 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28361459 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.27334006 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27079435 |
| 26 | Endocytosis_Homo sapiens_hsa04144 | 1.25943873 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.24304628 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.23930369 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23345074 |
| 30 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23014389 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.22770997 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.22248300 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.21965826 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.20924028 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20304441 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18451842 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14314592 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14037988 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13996674 |
| 40 | Salivary secretion_Homo sapiens_hsa04970 | 1.13886306 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.13572376 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13080719 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.13046020 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12014528 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.11078679 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 1.10885321 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09783041 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.08575798 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07744826 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06400163 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 1.06294044 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05420129 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04500471 |
| 54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04419572 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03955549 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03871083 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03251207 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.02595890 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01974060 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01074139 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00918901 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00897796 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99268169 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.99002264 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96993579 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96085733 |
| 67 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95621801 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.94400202 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.93885410 |
| 70 | Axon guidance_Homo sapiens_hsa04360 | 0.93372982 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.92782659 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92321839 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92316638 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.92141687 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.89628587 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89046513 |
| 77 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87640708 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.86877925 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86452195 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86424143 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86365469 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86177908 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85533384 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.84328921 |
| 85 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83551899 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83534586 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83278868 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82720730 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82189760 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.81963575 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80496758 |
| 92 | Measles_Homo sapiens_hsa05162 | 0.80283851 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79705781 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79160036 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78886550 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78691416 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78473739 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.77526692 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77075598 |
| 100 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76549838 |
| 101 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75870152 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74858692 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74709875 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73922363 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72944509 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71781994 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70776737 |
| 108 | Phototransduction_Homo sapiens_hsa04744 | 0.67843343 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.67808054 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66692657 |
| 111 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.66094626 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65104793 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64760976 |
| 114 | Asthma_Homo sapiens_hsa05310 | 0.63976751 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62912957 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60517088 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60355942 |
| 118 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58573716 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58149551 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.58147924 |
| 121 | Homologous recombination_Homo sapiens_hsa03440 | 0.57512602 |
| 122 | Gap junction_Homo sapiens_hsa04540 | 0.57197881 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51800674 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51459691 |
| 125 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48076653 |
| 126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44712837 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.35577273 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35293427 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.32591200 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31951911 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30919005 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29683771 |
| 133 | Mismatch repair_Homo sapiens_hsa03430 | 0.29394428 |
| 134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29342783 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29160974 |

